Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Autor: | Bonner, James A, Harari, Paul M, Giralt, Jordi, Cohen, Roger B, Jones, Christopher U, Sur, Ranjan K, Raben, David, Baselga, Jose, Spencer, Sharon A, Zhu, Junming, Youssoufian, Hagop, Rowinsky, Eric K, Ang, K Kian |
---|---|
Zdroj: | In Lancet Oncology 2010 11(1):21-28 |
Databáze: | ScienceDirect |
Externí odkaz: |